Literature DB >> 3396281

Vocal quality 10 years after radiotherapy for early glottic cancer.

D A Morgan1, H F Robinson, L Marsh, P J Bradley.   

Abstract

The voices of 12 patients who had been treated by radiotherapy for Stage I squamous carcinoma of the glottis at least 10 years previously, and who had shown no signs of recurrent disease, were assessed. A speech therapist detected significant abnormalities in all patients, but these did not detract from the overall high satisfaction of the patients with their voice quality.

Entities:  

Mesh:

Year:  1988        PMID: 3396281     DOI: 10.1016/s0009-9260(88)80541-5

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  Voice quality assessment after laryngeal cancer radiotherapeutic treatment at initial stages.

Authors:  M Jesús Caminero Cueva; Blanca Señaris González; Aurora López Llames; Faustino Núñez Batalla; Ramón Alonso Pantiga; Carlos Suárez Nieto
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

2.  Acoustic voice analysis in different phonetic contexts after larynx radiotherapy for T1 vocal cord carcinoma.

Authors:  Angeles Rovirosa; Carlos Ascaso; Rosa Abellana; Eugenio Martínez-Celdrán; Alicia Ortega; Mercedes Velasco; Montserrat Bonet; Teresa Herrero; Meritxell Arenas; Albert Biete
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

3.  Quality of life, functional outcome, and voice handicap index in partial laryngectomy patients for early glottic cancer.

Authors:  Tolga Kandogan; Aylin Sanal
Journal:  BMC Ear Nose Throat Disord       Date:  2005-05-12

4.  Voice rehabilitation after laryngeal cancer: Associated effects on psychological well-being.

Authors:  Liza Bergström; Elizabeth C Ward; Caterina Finizia
Journal:  Support Care Cancer       Date:  2017-04-02       Impact factor: 3.603

5.  Cost-effectiveness analysis of voice rehabilitation for patients with laryngeal cancer: a randomized controlled study.

Authors:  Mia Johansson; Caterina Finizia; Josefine Persson; Lisa Tuomi
Journal:  Support Care Cancer       Date:  2020-02-20       Impact factor: 3.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.